Patrick Lindsay, president of UBC sits down with Editorial Director William Looney to discusses the issues UBC confronts as it offers support services to pharmaceutical companies
Patrick Lindsay, president of UBC sits down with Editorial Director Bill Loony to discusses the issues UBC confronts as it offers support services to pharmaceutical companies.
Craig Tooman: Silencing the Distractions
June 13th 2024Craig Tooman, CEO of Silence Therapeutics, on steering through the rough biotech funding and investment waters post-pandemic—and how a retooled organizational approach has the company in a stronger position today in the growing field of gene silencing through siRNA drugs.
Yvonne Greenstreet: Answering the Call
May 10th 2024From Big Pharma to biotech—and a globe-spanning journey along the way—Yvonne Greenstreet, this year’s Healthcare Businesswomen’s Association Woman of the Year, is right where she wants to be: leading efforts to advance “bold ideas” in RNAi therapeutics into life-changing gains for patients.